11-63575038-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001128203.2(PLAAT3):c.396T>A(p.Asp132Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,609,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001128203.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PLAAT3 | NM_001128203.2 | c.396T>A | p.Asp132Glu | missense_variant | 5/5 | ENST00000415826.3 | |
PLAAT3 | NM_007069.3 | c.396T>A | p.Asp132Glu | missense_variant | 4/4 | ||
PLAAT3 | XM_011544741.2 | c.441T>A | p.Asp147Glu | missense_variant | 4/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PLAAT3 | ENST00000415826.3 | c.396T>A | p.Asp132Glu | missense_variant | 5/5 | 2 | NM_001128203.2 | P1 | |
PLAAT3 | ENST00000323646.9 | c.396T>A | p.Asp132Glu | missense_variant | 4/4 | 1 | P1 | ||
PLAAT3 | ENST00000394613.3 | n.490T>A | non_coding_transcript_exon_variant | 4/4 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152258Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000522 AC: 13AN: 249264Hom.: 0 AF XY: 0.0000445 AC XY: 6AN XY: 134870
GnomAD4 exome AF: 0.0000124 AC: 18AN: 1456812Hom.: 0 Cov.: 28 AF XY: 0.00000965 AC XY: 7AN XY: 725104
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152258Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74392
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 16, 2023 | The c.396T>A (p.D132E) alteration is located in exon 4 (coding exon 4) of the PLA2G16 gene. This alteration results from a T to A substitution at nucleotide position 396, causing the aspartic acid (D) at amino acid position 132 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at